Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AmerisourceBergen Settlement On Injectable Drug Repackaging Includes Forfeiture Of Exec Pay

Oct 03 2018

• By Brenda Sandburg

Vial syringe_1017883366_1200.jpg

Related Content

GSK’s DoJ Settlement Requires Execs To Forfeit Bonuses If Misconduct Occurs

Jul 02 2012

AmerisourceBergen Oncology Drug Repackaging Program Draws $260m Fine

Sep 28 2017

Health Care Fraud Investigations Bedevil Pharma Industry: If You're Not Under Investigation, It's Only Because You've Recently Settled

Nov 16 2009

J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Nov 05 2013

Related Companies

Cencora, Inc

GSK plc

Johnson & Johnson

Par Pharmaceutical Companies Inc.

Johnson & Johnson

Eisai Co., Ltd.

Helsinn Healthcare SA

Genentech, Inc.

Sanofi

Amgen, Inc.

McKesson Corp.

Additional Topics

United States Legal Issues Compliance Manufacturing Policy Cancer BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window